Twin Tree Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-513,621
| Closed | -$46.2M | – | 1700 |
|
|
2024
Q3 | $43.1M | Buy |
513,621
+250,692
| +95% | +$19.1M | 0.08% | 196 |
|
|
2024
Q2 | $18M | Buy |
+262,929
| New | +$17.5M | 0.04% | 401 |
|
|
2024
Q1 | – | Sell |
-310,462
| Closed | -$23.9M | – | 1408 |
|
|
2023
Q4 | $25.2M | Buy |
+310,462
| New | +$24.2M | 0.05% | 396 |
|
|
2023
Q3 | – | Sell |
-124,076
| Closed | -$9.54M | – | 1329 |
|
|
2023
Q2 | $9.56M | Sell |
124,076
-19,141
| -13% | -$1.53M | 0.01% | 627 |
|
|
2023
Q1 | $11.9M | Sell |
143,217
-175,125
| -55% | -$14.5M | 0.02% | 533 |
|
|
2022
Q4 | $27.3M | Buy |
318,342
+213,174
| +203% | +$16.9M | 0.06% | 308 |
|
|
2022
Q3 | $6.49M | Sell |
105,168
-62,130
| -37% | -$3.92M | 0.01% | 696 |
|
|
2022
Q2 | $10.3M | Buy |
+167,298
| New | +$10.4M | 0.02% | 633 |
|
|
2022
Q1 | – | Sell |
-489,888
| Closed | -$31.3M | – | 1724 |
|
|
2021
Q4 | $35.6M | Buy |
489,888
+232,373
| +90% | +$16M | 0.07% | 249 |
|
|
2021
Q3 | $18M | Buy |
257,515
+101,080
| +65% | +$7.1M | 0.04% | 393 |
|
|
2021
Q2 | $10.8M | Buy |
156,435
+27,760
| +22% | +$1.85M | 0.03% | 492 |
|
|
2021
Q1 | $8.32M | Sell |
128,675
-250,151
| -66% | -$16.1M | 0.03% | 505 |
|
|
2020
Q4 | $22.1M | Sell |
378,826
-36,128
| -9% | -$2.18M | 0.09% | 256 |
|
|
2020
Q3 | $26.2M | Buy |
414,954
+323,703
| +355% | +$22.4M | 0.11% | 206 |
|
|
2020
Q2 | $7.02M | Sell |
91,251
-53,280
| -37% | -$4.08M | 0.03% | 555 |
|
|
2020
Q1 | $10.8M | Buy |
144,531
+108,572
| +302% | +$7.5M | 0.05% | 310 |
|
|
2019
Q4 | $2.34M | Sell |
35,959
-32,719
| -48% | -$2.13M | 0.01% | 684 |
|
|
2019
Q3 | $4.35M | Sell |
68,678
-32,437
| -32% | -$2.12M | 0.02% | 513 |
|
|
2019
Q2 | $6.83M | Buy |
+101,115
| New | +$6.65M | 0.03% | 381 |
|
|
2019
Q1 | – | Sell |
-14,956
| Closed | -$994K | – | 1416 |
|
|
2018
Q4 | $935K | Sell |
14,956
-22,138
| -60% | -$1.55M | 0.01% | 865 |
|
|
2018
Q3 | $2.86M | Sell |
37,094
-21,722
| -37% | -$1.64M | 0.02% | 513 |
|
|
2018
Q2 | $4.17M | Sell |
58,816
-21,710
| -27% | -$1.53M | 0.03% | 475 |
|
|
2018
Q1 | $6.07M | Buy |
80,526
+76,648
| +1,976% | +$6.09M | 0.05% | 305 |
|
|
2017
Q4 | $278K | Sell |
3,878
-59,030
| -94% | -$4.48M | ﹤0.01% | 867 |
|
|
2017
Q3 | $5.1M | Sell |
62,908
-18,667
| -23% | -$1.43M | 0.04% | 369 |
|
|
2017
Q2 | $5.77M | Buy |
81,575
+47,420
| +139% | +$3.16M | 0.05% | 355 |
|
|
2017
Q1 | $2.32M | Sell |
34,155
-39,384
| -54% | -$2.77M | 0.02% | 522 |
|
|
2016
Q4 | $5.27M | Sell |
73,539
-11,605
| -14% | -$863K | 0.05% | 385 |
|
|
2016
Q3 | $6.74M | Buy |
85,144
+26,012
| +44% | +$2.11M | 0.09% | 226 |
|
|
2016
Q2 | $4.93M | Buy |
59,132
+34,009
| +135% | +$3.02M | 0.08% | 260 |
|
|
2016
Q1 | $2.31M | Buy |
25,123
+19,142
| +320% | +$1.73M | 0.04% | 385 |
|
|
2015
Q4 | $605K | Buy |
+5,981
| New | +$622K | 0.01% | 807 |
|
|
2015
Q2 | – | Sell |
-14,702
| Closed | -$1.61M | – | 1371 |
|
|
2015
Q1 | $1.44M | Sell |
14,702
-11,154
| -43% | -$1.13M | 0.04% | 487 |
|
|
2014
Q4 | $2.44M | Sell |
25,856
-15,033
| -37% | -$1.55M | 0.07% | 324 |
|
|
2014
Q3 | $4.35M | Buy |
+40,889
| New | +$4M | 0.12% | 198 |
|
|
2014
Q2 | – | Sell |
-12,928
| Closed | -$1.01M | – | 947 |
|
|
2014
Q1 | $916K | Buy |
+12,928
| New | +$1.01M | 0.02% | 635 |
|
|
2013
Q4 | – | Sell |
-9,511
| Closed | -$662K | – | 958 |
|
|
2013
Q3 | $598K | Buy |
+9,511
| New | +$568K | 0.02% | 564 |
|
Other funds holding GILD
VCM
VPM
Twin Tree Management's GILD Position: Q4 2024 in Review
Twin Tree Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 513,621 shares — an estimated $46.2M sold.
Twin Tree Management first reported a position in GILD in Q3 2013 and held it in 37 quarters. The position peaked at $43.1M in Q3 2024. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Twin Tree Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
- Twin Tree Management sold 513,621 Gilead Sciences shares in Q4 2024, an estimated $46.2M.
- Twin Tree Management first reported a position in Gilead Sciences in Q3 2013 and held it in 37 quarters.
- Twin Tree Management's Gilead Sciences position peaked at $43.1M in Q3 2024.
- 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Twin Tree Management's 13F filing for Q4 2024, filed 10 Feb 2025.